NaturalNews.com (staff article et al., 2025-06-04: NaturalNews article announcing the Healing Revolution docu-series (premiere June 7 on BrightU.com), listing methylene blue photodynamic therapy among the series' topics and citing a 49% prostate-cancer remission figure from a 413-patient study – but describing no individual remission cases and never naming the photosensitizer used in that prostate study.
Methylene Blue & Photodynamic Therapy: When activated by light, this compound destroys cancer cells while protecting brain function.
NaturalNews.com (staff article et al., 2025-06-04: NaturalNews article announcing the Healing Revolution docu-series (premiere June 7 on BrightU.com), listing methylene blue photodynamic therapy among the series' topics and citing a 49% prostate-cancer remission figure from a 413-patient study – but describing no individual remission cases and never naming the photosensitizer used in that prostate study. C9 NaturalNews 2025-06-04. Study type: promotional news article for a commercial docuseries (unpaid listing of series contents). Country: USA. Publisher: NaturalNews.com, founded by Mike Adams; article bylined to the site. Recorded as the source says it, attributed; nothing here is called false. Key point for the record: the article attributes 'destroying cancer cells while protecting brain function' to methylene blue PDT but gives no patient case, no dose, no clinic, and no citation for the 49% prostate figure. The prostate figure matches the padeliporfin PCM301 phase 3 trial (see row for PMID 28007457), which used padeliporfin, not methylene blue. Study type: news.
